Back to User profile » Dr Yingliang Wang
Papers published by Dr Yingliang Wang:
Synergistic Effects of Nanoscale CaO2 Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination
Wang Y, Ju S, Zhou H, Bai Y, Zhou C, Liu J, Dong X, Zheng C
International Journal of Nanomedicine 2024, 19:137-154
Published Date: 5 January 2024
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
Li T, Shi Q, Liu J, Wang Y, Zhou C, Wang C, Ju S, Huang S, Yang C, Chen Y, Bai Y, Xiong B
Journal of Hepatocellular Carcinoma 2021, 8:1525-1535
Published Date: 3 December 2021
Transcatheter Arterial Embolization Containing Donafenib Induces Anti-Angiogenesis and Tumoricidal CD8+ T-Cell Infiltration in Rabbit VX2 Liver Tumor
Shi Q, Li T, Huang S, Bai Y, Wang Y, Liu J, Zhou C, Chen Y, Xiong B
Cancer Management and Research 2021, 13:6943-6952
Published Date: 7 September 2021
Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Wang Y, Zhou C, Liu J, Shi Q, Huang S, Yang C, Li T, Chen Y, Xiong B
Cancer Management and Research 2021, 13:6935-6941
Published Date: 7 September 2021
Endovascular Management of Intractable Nasopharyngeal Hemorrhage in Patients Irradiated for Nasopharyngeal Carcinoma: A Twelve-Year Experience
Wang Y, Dong X, Zhou C, Shi Q, Liu J, Xiong B
Cancer Management and Research 2020, 12:11945-11952
Published Date: 20 November 2020